This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Sep;8(9):695-6.

doi: 10.1038/nrd2982.

Golimumab

Dimitrios A Pappas, Joan M Bathon, Delphine Hanicq, Uma Yasothan, Peter Kirkpatrick

PMID: 19721444
DOI: 10.1038/nrd2982

Golimumab

Dimitrios A Pappas et al. Nat Rev Drug Discov. 2009 Sep.

. 2009 Sep;8(9):695-6.

doi: 10.1038/nrd2982.

Authors

Dimitrios A Pappas, Joan M Bathon, Delphine Hanicq, Uma Yasothan, Peter Kirkpatrick

PMID: 19721444
DOI: 10.1038/nrd2982

No abstract available

PubMed Disclaimer

Similar articles

Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Oldfield V, Plosker GL. Oldfield V, et al. BioDrugs. 2009;23(2):125-35. doi: 10.2165/00063030-200923020-00005. BioDrugs. 2009. PMID: 19489653 Review.
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Rossini M, Viapiana O, Orsolini G, Fracassi E, Idolazzi L, Gatti D, Adami S, Govoni M. Rossini M, et al. Reumatismo. 2015 Mar 31;66(4):285-303. doi: 10.4081/reumatismo.2014.799. Reumatismo. 2015. PMID: 25829189 Review.
Golimumab (simponi) for inflammatory arthritis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Jul 13;51(1316):55-6. Med Lett Drugs Ther. 2009. PMID: 19590489 No abstract available.
Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Voulgari PV. Voulgari PV. Expert Rev Clin Immunol. 2010 Sep;6(5):721-33. doi: 10.1586/eci.10.49. Expert Rev Clin Immunol. 2010. PMID: 20828280 Review.
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Kay J, Fleischmann R, Keystone E, Hsia EC, Hsu B, Mack M, Goldstein N, Braun J, Kavanaugh A. Kay J, et al. Ann Rheum Dis. 2015 Mar;74(3):538-46. doi: 10.1136/annrheumdis-2013-204195. Epub 2013 Dec 16. Ann Rheum Dis. 2015. PMID: 24344160 Free PMC article. Clinical Trial.

See all similar articles

Cited by

Fresh from the biologic pipeline-2009.
Sheridan C. Sheridan C. Nat Biotechnol. 2010 Apr;28(4):307-10. doi: 10.1038/nbt0410-307. Nat Biotechnol. 2010. PMID: 20379168 No abstract available.
Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists.
Urbano PC, Soccol VT, Azevedo VF. Urbano PC, et al. Biologics. 2014 Jul 31;8:211-20. doi: 10.2147/BTT.S57253. eCollection 2014. Biologics. 2014. PMID: 25114503 Free PMC article. Review.
Abatacept, Golimumab, and Sarilumab as Selected Bio-Originator Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action in Their Current Use in Treatment.
Kawczak P, Feszak IJ, Bączek T. Kawczak P, et al. J Clin Med. 2025 Mar 19;14(6):2107. doi: 10.3390/jcm14062107. J Clin Med. 2025. PMID: 40142915 Free PMC article. Review.
Golimumab for rheumatoid arthritis.
Singh JA, Noorbaloochi S, Singh G. Singh JA, et al. Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD008341. doi: 10.1002/14651858.CD008341. Cochrane Database Syst Rev. 2010. PMID: 20091667 Free PMC article.
Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications.
Wang J, Wang YM, Ahn HY. Wang J, et al. AAPS J. 2014 Sep;16(5):938-47. doi: 10.1208/s12248-014-9637-0. Epub 2014 Jul 4. AAPS J. 2014. PMID: 24993574 Free PMC article. Review.

See all "Cited by" articles

References

1. Arthritis Rheum. 2008 Nov;58(11):3402-12 - PubMed
1. Curr Opin Pharmacol. 2007 Aug;7(4):412-7 - PubMed
1. Arthritis Rheum. 2006 Apr;54(4):1063-74 - PubMed
1. Curr Opin Immunol. 2008 Aug;20(4):450-9 - PubMed
1. Ann Rheum Dis. 2009 Jun;68(6):789-96 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information